Exome Asset Management Exits $5.49 Million Stake in Wave Life Sciences Amid Rough First Quarter
On May 15, 2026, Exome Asset Management liquidated its entire stake of 421,488 shares in Wave Life Sciences for an estimated $5.49 million based on first-quarter average pricing. The move comes after the company's position lost value by $7.17 million during Q1 due to price fluctuations and trading activity.
Tickers: $WVE
Topics: biotech SEC filings stock trading